• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定肉瘤中具有预后意义的可变剪接事件。

Identification of prognostic alternative splicing events in sarcoma.

机构信息

Department of Emergency Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

Department of Operation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.

出版信息

Sci Rep. 2021 Jul 22;11(1):14949. doi: 10.1038/s41598-021-94485-x.

DOI:10.1038/s41598-021-94485-x
PMID:34294833
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8298452/
Abstract

Sarcoma is a rare malignancy with unfavorable prognoses. Accumulating evidence indicates that aberrant alternative splicing (AS) events are generally involved in cancer pathogenesis. The aim of this study was to identify the prognostic value of AS-related survival genes as potential biomarkers, and highlight the functional roles of AS events in sarcoma. RNA-sequencing and AS-event datasets were downloaded from The Cancer Genome Atlas (TCGA) sarcoma cohort and TCGA SpliceSeq, respectively. Survival-related AS events were further assessed using a univariate analysis. A multivariate Cox regression analysis was also performed to establish a survival-gene signature to predict patient survival, and the area-under-the-curve method was used to evaluate prognostic reliability. KOBAS 3.0 and Cytoscape were used to functionally annotate AS-related genes and to assess their network interactions. We detected 9674 AS events in 40,184 genes from 236 sarcoma samples, and the 15 most significant genes were then used to construct a survival regression model. We further validated the involvement of ten potential survival-related genes (TUBB3, TRIM69, ZNFX1, VAV1, KCNN2, VGLL3, AK7, ARMC4, LRRC1, and CRIP1) in the occurrence and development of sarcoma. Multivariate survival model analyses were also performed, and validated that a model using these ten genes provided good classifications for predicting patient outcomes. The present study has increased our understanding of AS events in sarcoma, and the gene-based model using AS-related events may serve as a potential predictor to determine the survival of sarcoma patients.

摘要

肉瘤是一种预后不良的罕见恶性肿瘤。越来越多的证据表明,异常的选择性剪接(AS)事件通常与癌症的发病机制有关。本研究旨在确定 AS 相关生存基因作为潜在生物标志物的预后价值,并强调 AS 事件在肉瘤中的功能作用。从癌症基因组图谱(TCGA)肉瘤队列和 TCGA SpliceSeq 分别下载了 RNA-seq 和 AS 事件数据集。进一步使用单因素分析评估了与生存相关的 AS 事件。还进行了多变量 Cox 回归分析,以建立一个用于预测患者生存的生存基因特征,并使用曲线下面积方法评估预后可靠性。使用 KOBAS 3.0 和 Cytoscape 对 AS 相关基因进行功能注释,并评估它们的网络相互作用。我们从 236 个肉瘤样本中的 40,184 个基因中检测到 9674 个 AS 事件,然后使用 15 个最重要的基因构建了一个生存回归模型。我们进一步验证了十个潜在的与生存相关的基因(TUBB3、TRIM69、ZNFX1、VAV1、KCNN2、VGLL3、AK7、ARMC4、LRRC1 和 CRIP1)在肉瘤的发生和发展中的作用。还进行了多变量生存模型分析,并验证了使用这十个基因的模型可以很好地对患者的预后进行分类。本研究增加了我们对肉瘤中 AS 事件的理解,并且基于基因的使用 AS 相关事件的模型可能作为预测肉瘤患者生存的潜在预测因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1af/8298452/3c06f91dfbf4/41598_2021_94485_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1af/8298452/9e76e1771b5c/41598_2021_94485_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1af/8298452/78c43413a9f9/41598_2021_94485_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1af/8298452/659c3703f9f5/41598_2021_94485_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1af/8298452/e7e299a5b9c5/41598_2021_94485_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1af/8298452/b74dc9538420/41598_2021_94485_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1af/8298452/3c06f91dfbf4/41598_2021_94485_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1af/8298452/9e76e1771b5c/41598_2021_94485_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1af/8298452/78c43413a9f9/41598_2021_94485_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1af/8298452/659c3703f9f5/41598_2021_94485_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1af/8298452/e7e299a5b9c5/41598_2021_94485_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1af/8298452/b74dc9538420/41598_2021_94485_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1af/8298452/3c06f91dfbf4/41598_2021_94485_Fig6_HTML.jpg

相似文献

1
Identification of prognostic alternative splicing events in sarcoma.鉴定肉瘤中具有预后意义的可变剪接事件。
Sci Rep. 2021 Jul 22;11(1):14949. doi: 10.1038/s41598-021-94485-x.
2
Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.基于癌症基因组图谱(TCGA)和SpliceSeq数据库的胃癌预后中可变剪接特征的综合分析
Med Sci Monit. 2020 Nov 21;26:e925772. doi: 10.12659/MSM.925772.
3
Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.利用癌症基因组图谱数据确定软组织肉瘤中可变剪接事件的预后意义。
J Transl Med. 2019 Aug 23;17(1):283. doi: 10.1186/s12967-019-2029-6.
4
Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.基于317例样本的剪接序列数据构建膀胱尿路上皮癌可变剪接事件的预后特征
Cell Physiol Biochem. 2018;48(3):1355-1368. doi: 10.1159/000492094. Epub 2018 Jul 26.
5
Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.系统分析剪接变异特征揭示了肾透明细胞癌的预后预测因子。
J Cell Physiol. 2019 Dec;234(12):22753-22764. doi: 10.1002/jcp.28840. Epub 2019 May 29.
6
Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.口腔鳞状细胞癌中预后性可变剪接标志的鉴定。
J Cell Physiol. 2020 May;235(5):4804-4813. doi: 10.1002/jcp.29357. Epub 2019 Oct 21.
7
Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.肺腺癌中预后替代剪接特征和剪接因子的全基因组分析。
Genes (Basel). 2020 Oct 31;11(11):1300. doi: 10.3390/genes11111300.
8
Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma.剪接事件作为葡萄膜黑色素瘤预后的指标。
Genes (Basel). 2020 Feb 21;11(2):227. doi: 10.3390/genes11020227.
9
Characterization of alternative splicing events and prognostic signatures in breast cancer.乳腺癌中可变剪接事件和预后特征的分析。
BMC Cancer. 2021 May 22;21(1):587. doi: 10.1186/s12885-021-08305-6.
10
Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.乳头状肾细胞癌中新型预后性可变剪接特征的鉴定
J Cell Biochem. 2020 Jan;121(1):672-689. doi: 10.1002/jcb.29314. Epub 2019 Aug 12.

引用本文的文献

1
ZNFX1 suppresses apoptosis-associated mRNA stability in cardiomyocyte to protect against myocardial infarction.锌指蛋白X连锁1(ZNFX1)抑制心肌细胞中与凋亡相关的mRNA稳定性,以预防心肌梗死。
Redox Biol. 2025 Jun 10;85:103706. doi: 10.1016/j.redox.2025.103706.
2
Clinical and Prognostic Implications of an Alternative Splicing-related Risk Model Based on TP53 Status in Breast Cancer.基于TP53状态的剪接相关风险模型在乳腺癌中的临床及预后意义
Curr Pharm Biotechnol. 2025;26(2):246-259. doi: 10.2174/0113892010283176240212073417.
3
Global profiling of alternative splicing in non-small cell lung cancer reveals novel histological and population differences.

本文引用的文献

1
KEGG: integrating viruses and cellular organisms.KEGG:整合病毒和细胞生物。
Nucleic Acids Res. 2021 Jan 8;49(D1):D545-D551. doi: 10.1093/nar/gkaa970.
2
TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma.TUBB3 与肾透明细胞癌的高级别组织学、不良预后、p53 表达和癌症干细胞标志物相关。
Oncology. 2020;98(10):689-698. doi: 10.1159/000506775. Epub 2020 Jun 25.
3
LncRNA ZNFX1-AS1 targeting miR-193a-3p/SDC1 regulates cell proliferation, migration and invasion of bladder cancer cells.
非小细胞肺癌中可变剪接的全基因组分析揭示了新的组织学和人群差异。
Oncogene. 2025 Apr;44(14):958-967. doi: 10.1038/s41388-024-03267-y. Epub 2025 Jan 10.
4
Plasma membrane SK2 channel activity regulates migration and chemosensitivity of high-grade serous ovarian cancer cells.质膜SK2通道活性调节高级别浆液性卵巢癌细胞的迁移和化学敏感性。
Mol Oncol. 2024 Aug;18(8):1853-1865. doi: 10.1002/1878-0261.13631. Epub 2024 Mar 13.
5
Outer dynein arm docking complex subunit 2 polymorphism rs7893462 modulates hepatocellular carcinoma susceptibility and can serve as an overall survival biomarker for hepatitis B virus-related hepatocellular carcinoma after hepatectomy: a cohort study with a long-term follow-up.外动力蛋白臂对接复合物亚基 2 多态性 rs7893462 调节肝细胞癌易感性,并可作为乙型肝炎病毒相关肝细胞癌肝切除术后总生存期的生物标志物:一项具有长期随访的队列研究。
World J Surg Oncol. 2023 Oct 13;21(1):322. doi: 10.1186/s12957-023-03205-4.
6
A new molecular subclassification and predictions for diagnosis and prognosis of papillary thyroid cancer by alternative splicing profile.基于可变剪接图谱的甲状腺乳头状癌新分子亚分类及诊断与预后预测
Front Pharmacol. 2023 Mar 6;14:1119789. doi: 10.3389/fphar.2023.1119789. eCollection 2023.
长链非编码 RNA ZNFX1-AS1 通过靶向 miR-193a-3p/SDC1 调节膀胱癌细胞的增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2020 May;24(9):4719-4728. doi: 10.26355/eurrev_202005_21160.
4
Starvation-induced suppression of DAZAP1 by miR-10b integrates splicing control into TSC2-regulated oncogenic autophagy in esophageal squamous cell carcinoma.饥饿诱导的 miR-10b 对 DAZAP1 的抑制作用将剪接调控整合到 TSC2 调控的食管鳞癌细胞癌性自噬中。
Theranostics. 2020 Apr 6;10(11):4983-4996. doi: 10.7150/thno.43046. eCollection 2020.
5
Elevated level of Vav1 was correlated with advanced biological behavior and poor prognosis in patients with gastric cancer.Vav1水平升高与胃癌患者的晚期生物学行为及不良预后相关。
Int J Clin Exp Pathol. 2018 Jan 1;11(1):391-398. eCollection 2018.
6
Genome-wide profiling of prognosis-related alternative splicing signatures in sarcoma.肉瘤中预后相关可变剪接特征的全基因组分析。
Ann Transl Med. 2019 Oct;7(20):557. doi: 10.21037/atm.2019.09.65.
7
Vesicular Stomatitis Virus Transcription Is Inhibited by TRIM69 in the Interferon-Induced Antiviral State.囊膜口炎病毒转录在干扰素诱导的抗病毒状态下受到 TRIM69 的抑制。
J Virol. 2019 Nov 26;93(24). doi: 10.1128/JVI.01372-19. Print 2019 Dec 15.
8
Role of Alternative Splicing in Prostate Cancer Aggressiveness and Drug Resistance in African Americans.剪接变异在非裔美国人前列腺癌侵袭性和耐药中的作用。
Adv Exp Med Biol. 2019;1164:119-139. doi: 10.1007/978-3-030-22254-3_10.
9
SRSF1 and RBM4 differentially modulate the oncogenic effect of HIF-1α in lung cancer cells through alternative splicing mechanism.SRSF1 和 RBM4 通过选择性剪接机制差异调节肺癌细胞中 HIF-1α 的致癌作用。
Biochim Biophys Acta Mol Cell Res. 2019 Dec;1866(12):118550. doi: 10.1016/j.bbamcr.2019.118550. Epub 2019 Sep 3.
10
Discovery of Aberrant Alteration of Genome in Colorectal Cancer by Exome Sequencing.外显子组测序发现结直肠癌基因组异常改变。
Am J Med Sci. 2019 Nov;358(5):340-349. doi: 10.1016/j.amjms.2019.07.012. Epub 2019 Aug 1.